PharmaBlock Sciences (Nanjing), Inc. (SHE:300725)

SHE:300725 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	280.27	290.2	511.19	1,150	699.63	1,245
Short-Term Investments	-	618.48	984.26	303.46	100.74	25
Trading Asset Securities	623.53	465.61	105.35	163.3	304.43	107.62
Cash & Short-Term Investments	903.8	1,374	1,601	1,617	1,105	1,377
Cash Growth	51.51%	-14.15%	-1.01%	46.38%	-19.79%	511.93%
Accounts Receivable	349.85	483.69	473.66	330.61	201.27	167.08
Other Receivables	2.68	1.92	2.62	1.83	2.11	1.31
Receivables	352.53	485.61	476.28	332.44	203.38	168.39
Inventory	673.41	840.17	724.79	676.39	447.94	309.63
Other Current Assets	733.25	16.88	15.88	33.8	47.89	17.77
Total Current Assets	2,663	2,717	2,818	2,660	1,804	1,873
Property, Plant & Equipment	1,631	1,684	1,753	1,661	1,173	309.36
Long-Term Investments	2,976	19.86	5.48	5.66	8.91	156.97
Goodwill	355.74	355.74	356.19	356.19	356.19	31.2
Other Intangible Assets	103.78	107.98	109.42	111.48	111.47	33.83
Long-Term Deferred Tax Assets	36.38	32.63	38.61	35.8	15.1	11.66
Long-Term Deferred Charges	5.57	6.94	10.14	9.18	7.24	2.35
Other Long-Term Assets	23.07	10.99	13.1	22.8	30.74	6.71
Total Assets	7,795	4,935	5,104	4,862	3,507	2,425
Accounts Payable	262.73	292.2	278.7	413.47	267.35	183.68
Accrued Expenses	72.01	91	104.71	88.18	60.61	30.72
Short-Term Debt	100	230.27	236.5	163.4	347.64	120.44
Current Portion of Long-Term Debt	1.53	52.74	371.43	17.29	7.95	-
Current Portion of Leases	-	1.26	1.99	-	1.82	-
Current Income Taxes Payable	26.96	16.96	15.7	0.85	0.15	10.84
Current Unearned Revenue	105.67	56.28	32.73	39.63	28.7	57.32
Other Current Liabilities	11.29	8.53	14.33	16.35	74.66	72.94
Total Current Liabilities	580.19	749.23	1,056	739.18	788.88	475.94
Long-Term Debt	-	1,127	1,138	1,392	23.6	-
Long-Term Leases	2.15	3.21	0.23	-	-	-
Long-Term Unearned Revenue	42.7	46.61	52.64	52.85	54.14	53.63
Long-Term Deferred Tax Liabilities	19.71	22.13	24.31	20.15	12.58	1
Total Liabilities	645.64	1,948	2,272	2,205	879.21	530.57
Common Stock	233.81	199.73	199.66	199.66	199.7	153.62
Additional Paid-In Capital	2,346	1,096	1,090	1,075	1,299	1,313
Retained Earnings	1,654	1,597	1,439	1,261	967.1	495.91
Treasury Stock	-30.04	-30.04	-20.03	-	-35	-64.58
Comprehensive Income & Other	2,945	125.24	123.52	121.74	-3.44	-3.13
Total Common Equity	7,149	2,988	2,832	2,658	2,427	1,895
Minority Interest	-	-	-	0	200.29	0
Shareholders' Equity	7,149	2,988	2,832	2,658	2,628	1,895
Total Liabilities & Equity	7,795	4,935	5,104	4,862	3,507	2,425
Total Debt	103.68	1,414	1,749	1,573	381.02	120.44
Net Cash (Debt)	800.12	-39.71	-147.83	44.11	723.78	1,257
Net Cash Growth	-	-	-	-93.91%	-42.42%	663.04%
Net Cash Per Share	3.97	-0.20	-0.73	0.22	3.63	6.69
Filing Date Shares Outstanding	200.91	198.89	198.83	199.66	199.7	199.7
Total Common Shares Outstanding	200.91	198.89	198.83	199.66	199.7	199.7
Working Capital	2,083	1,968	1,762	1,921	1,015	1,397
Book Value Per Share	35.58	15.02	14.24	13.31	12.16	9.49
Tangible Book Value	6,689	2,524	2,367	2,190	1,960	1,830
Tangible Book Value Per Share	33.30	12.69	11.90	10.97	9.81	9.16
Buildings	-	950.4	905.31	844.6	344.88	81.95
Machinery	-	1,052	1,025	792.72	510.13	151.75
Construction In Progress	-	232.68	256.23	357.53	575.32	171.25

Source: S&P Global Market Intelligence. Standard template. Financial Sources.